Support Line: 0300 373 8500
This year WMUK is bringing personalised patient support and expert information to your region.
Learn about clinical trials for Waldenstrom’s macroglobulinaemia, find out how to take part, & discover trials that are currently running in the UK
Waldenstrom’s macroglobulinaemia (WM) is a rare type of blood cancer. It has its own distinct characteristics that require specialised treatment and care. Our vision is that people affected by WM live longer, good quality lives supported every step of the way by WMUK.
We help people with Waldenstrom’s macroglobulinaemia (WM), a rare form of blood cancer, longer, better-quality lives.
We do this by providing essential resources for patients, families, and healthcare professionals. Whether you need to speak to a WM expert, want to learn about the condition or are a healthcare professional who wants to support a patient more effectively, we can help.
As the go-to source for WM clinicians, we work closely with the NHS and are leading the way in gathering data about the condition to improve understanding and treatment.
We’re here to help people with WM live longer, better lives — with WMUK supporting them every step of the way.
Want to understand more about WM and what to expect at each stage of your journey? With the help of WM experts, we’ve created a range of resources to guide you along the way.
We’re ready to help you live well with WM – whether you’re looking to join a Support Group, learn how to manage your symptoms, or get one-to-one advice through our Support Line.
Take a look around and explore all the extra information and support we offer. From details on the latest clinical trial to guidance for friends and family, you’ll find what you need right here.
Be the first to know about new resources, events and other WM by signing up to receive our communications.
The WMUK Board is responsible for the direction and governance of the organisation. Board members include experienced leaders and specialists who bring diverse expertise to steer WMUK towards achieving its mission.
The Patient Advisory Group (PAG) comprises 20 volunteers with direct experience of WM. Members review patient information, give feedback on new resources, and contribute to new programmes and long-term strategies.
WMUK’s core team manages the day-to-day running of the charity and its activities. The team develops resources, connects with healthcare professionals, produces information, and provides direct support to WM patients and their families.
